线粒体基因组变异和阿尔茨海默病
Maxim S Kozin1,2,3, Olga G Kulakova4,2,3, Ivan S Kiselev4,2,3
1Immanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia. kozinmax1992@gmail.com.
Biochemistry. Biokhimiia
|March 31, 2025
概括
线粒体DNA变异与阿尔茨海默病 (AD) 易感性有关. 本综述详细介绍了线粒体功能障碍和特定的mtDNA变化如何导致AD病变,尽管个体变异的意义需要进一步研究.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 是老年人认知能力下降的主要原因.
- 确切的原因和AD的机制仍然不完全理解.
- 线粒体功能障碍越来越被认为是AD神经退行症的关键因素.
研究的目的:
- 审查将线粒体功能障碍与阿尔茨海默病相关的证据.
- 探索线粒体DNA (mtDNA) 变异与AD之间的关联.
- 讨论mtDNA单基组和多形变体在AD易感性中的作用.
主要方法:
- 对阿尔茨海默病中线粒体功能障碍现有研究的审查.
- 对mtDNA变异 (半组和单个变异) 与AD之间的关联研究的分析.
- 检查对定义单元组的变异组组合效应的数据.
主要成果:
- 线粒体功能障碍是阿尔茨海默病中经常出现的发现.
- 在特定的线粒体DNA变异和AD之间存在显著的关联.
- mtDNA单基组和某些多态变体显示在AD易感性中起作用.
结论:
- 线粒体基因组内的变异在阿尔茨海默氏症易感性中起作用.
- 虽然mtDNA变异和AD之间的联系是显而易见的,但个体变异的确切影响需要进一步调查.
- 了解这些遗传联系可能会为阿尔茨海默病的发病过程提供新的见解.
相关概念视频
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


